The $3.1-Billion-Dollar Time Bomb That Could Sink Aurora Cannabis (TSX:ACB) Stock!

Aurora Cannabis Inc’s (TSX:ACB)(NYSE:ACB) balance sheet is loaded up with goodwill that may have to be written down

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) was one of the worst-performing cannabis stocks of 2019. Starting off the year at $7.02, it fell to $2.50 by year’s end–a stunning 64% decline.

All cannabis stocks did poorly in 2019, but ACB was one of the worst of the bunch thanks to its massive losses and hiccups in its European operations.

In 2020, the company is facing an even bigger threat. Threatening to give the company one of its largest losses ever, this $3.1 billion “time bomb” could send the stock below $1. Although this is not yet a “what-if”, it’s a major risk factor that many analysts are bracing for. And this year, the chickens may finally come home to roost.

A mountain of goodwill

As of its most recent earnings release, Aurora Cannabis had $3.1 billion worth of goodwill on its books. Goodwill is the acquisition premium above the book value of a company acquired.

Goodwill can be listed on a company’s balance sheet as an asset as long as it’s producing value for the acquiring company. However, goodwill has to be “tested” every year to make sure that its fair value still exceeds the book value of the acquired company. If it doesn’t, it has to be written down.

Why that’s bad news for investors

The reason why Aurora’s goodwill could be dangerous for investors is because there is a serious risk of some of it being impaired.

In the lead-up to legalization, there was a flurry of M&A activity in the cannabis sector, with extraordinary premiums having been paid for some of the acquired companies.

One cannabis acquisition that was particularly controversial was Aurora Cannabis’ purchase of MedReleaf for $2.64 billion U.S. (about $3.2 billion CAD). The all-stock deal heavily leveraged Aurora’s balance sheet, which the company justified on the basis that it would increase its production capacity.

However, just recently, Aurora sold off a major MedReleaf facility for just $17 million, a discount to what MedReleaf had paid for the facility prior to the sale, indicating that MedReleaf’s production numbers aren’t quite what Aurora had expected and that a big write-down may be on the horizon.

Foolish takeaway

Over the course of 2019, Aurora Cannabis’ shares fell far more than those of its peers. At the same time, its losses were nowhere near as bad as other cannabis companies like Canopy Growth, whose stock only fell 50% last year.

This suggests that ACB is being priced as though a major disaster is on the horizon. With $3.1 billion of goodwill sitting uncomfortably on the company’s balance sheet, we’ve got a likely culprit.

It remains to be seen whether Aurora Cannabis will take a huge impairment charge from its MedReleaf-related goodwill, but if it does, it will be bad news for those holding still holding onto ACB this coming February.

Should you invest $1,000 in Aurora Cannabis right now?

Before you buy stock in Aurora Cannabis, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurora Cannabis wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $18,391.46!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 35 percentage points since 2013*.

See the Top Stocks * Returns as of 1/7/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Cannabis Stocks

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »